Abstract
Two infants with human immunodeficiency virus (HIV) infection, encephalopathy, intrathecal anti-HIV IgG antibody production and (in one case) the presence of HIV antigen received monthly doses of intravenous gammaglobulin (IVGG) and daily antimicrobial prophylaxis starting at the ages of 6 and 9 months respectively. The follow-up over 15 and 12 months revealed a favourable course with remarkable improvement in visuo-spatial functions, receptive language, play behaviour and fine motor skills, as well as in muscle tone, pyramidal tract signs and vigilance in case 1, and near normalization in case 2. Viability of HIV in peripheral blood mononuclear cells, antigen in serum and cellular immunodeficiency, however, all remained unchanged. We suggest that neurological complications of encephalopathy in paediatric acquired immunodeficiency syndrome may have a slower progression when IVGG treatment plus antimicrobial prophylaxis is started early.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- cmv:
-
cytomegalovirus
- CSF:
-
cerebrospinal fluid
- HIV:
-
human immunodeficiency virus
- IVGG:
-
intravenous gammaglobulin
References
Bayley N (1969) Manual for the Bayley Scales of infant development. Institute of Human Development University of California, Berkeley. The Psychological Cooporation, New York
Belman AL, Ultman MH, Horoupian D, Novick B, Spiro AJ, Rubinstein A, Kurtzberg D, Cone-Wesson B (1985) Neurological complications in infants and children with acquired immune deficiency syndrome (AIDS). Ann Neurol 18:560–566
Belman AL, Diamond G, Dickons D, Horoupian D, Llena J, Lantos G, Rubinstein A (1988) Pediatric acquired immunodeficiency syndrome. Am J Dis Child 142:29–35
Blanche S, Fischer A, Le Deist F, Veber MD, Debre M, Chamaret S, Montagnier L, Griscelli C (1986) Longitudinal study of 18 children with perinatal LAV/HTLV III infection: attempt at prognostic evaluation. J Pediatr 109:965–970
Calvelli T, Rubinstein A (1986) Intravenous gammaglobulin in infant acquired immunodeficiency syndrome. Pediatr Infect Dis 5:207–210
Cowan MJ, Hellmann D, Chudwin D, Wara DW, Chang RS, Amman AJ (1984) Maternal transmission of acquired immune deficiency syndrome. Pediatrics 73:382–386
Epstein LG, Sharer LR, Oleske JM, Connor EM, Goudsmit J, Bagdon L, Robert-Guroff M, Koenigsberger MR (1986) Neurologic manifestations of human immune deficiency virus infection in children. Pediatrics 78:678–687
Gupta A, Novick B, Rubinstein A (1986) Restoration of suppressor T-cell functions in children with AIDS following intravenous gammaglobulin treatment. Am J Dis Child 140:143–146
Jovatsas E, Koch MA, Schäfer A, Stauber M, Löwenthal D (1985) LAV/HTLV-III in 20-week fetus. Lancet II:1129
Lampert R, Milberg J, O'Donell R, Kristal D, Thomas P (1986) Life table analysis of children with acquired immunodeficiency syndrome. Pediatr Infect Dis 5:374–375
Marion RW, Wiznia AA, Hutcheon GR, Rubinstein A (1986) Human T-cell lymphotropic virus Type III (HTLV-III) embryopathy. Am J Dis Child 140:638–640
Michaelis B, Walker CM, Legg H, Whalen M, Levy JA (1987) Use of PHA can interfere with efficient recovery of HIV from peripheral blood mononuclear cells. WP 13. III. International Conference on AIDS, Washington, D.C.
Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with a cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415–7419
Popovic M, Sarngadharan MG, Read E, Gallo RC (1984) Detection, isolation, and continous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500
Prader A, Budliger J (1977) Körpermasse, Wachstumsgeschwindigkeit und Knochenalter gesunder Kinder in den ersten 12 Jahren (Longitudinale Wachstumstudie Zürich). Helv Paediatr Acta [Suppl] 37:41–44
Prechtl HFR, Beintema DJ (1964) The neurological examination of the fullterm newborn infant. Clinics in Developmental Medizine, no. 12. Spastics Society with Heinemann, London
Robert-Guroff M, Oleske JM, Connor EM, Epstein LG, Minnefor AB, Gallo RC (1987) Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases. Pediatr Res 21:547–550
Schüpbach S, Tanner M (1986) Specificity of human immunodeficiency syndrome. Pediatr Infect Dis 5:374–375
Snider WD, Simpson DM, Nielsen S, Glod WM, Metroka CE, Posner JB (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14:403–418
Tardieux M, Blanche S, Rouzioux C, Veber F, Fischer A, Griscelli C (1987) Atteintes du système nerveux au cours des infections à HIV 1 du nourisson. Arch Fr Pediatr 44:495–499
Ultman MH, Belman AL, Ruff HA, Novick BE, Cone-Wesson B, Cohen HJ, Rubinstein A (1985) Developmental abnormalities in infants and children with AIDS and AIDS-related complex. Dev Med Child Neurol 27:563–571
Walker C, Moody D, Stites D, Levy JA (1986) CD 8 lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563–1566
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hunziker, U.A., Nadal, D., Jendis, J.B. et al. Stable human immunodeficiency virus encephalopathy in two infants receiving early intravenous gammaglobulin plus antimicrobial prophylaxis. Eur J Pediatr 148, 417–422 (1989). https://doi.org/10.1007/BF00595901
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00595901